MJ Gleeson (LON:GLE – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at Berenberg Bank in a report released on Tuesday,London Stock Exchange reports. They currently have a GBX 500 price target on the stock. Berenberg Bank’s target price would indicate a potential upside of 50.04% from the stock’s current price.
MJ Gleeson Stock Down 0.5%
GLE stock traded down GBX 1.76 during trading on Tuesday, reaching GBX 333.24. The stock had a trading volume of 69,845 shares, compared to its average volume of 153,625. MJ Gleeson has a one year low of GBX 326 and a one year high of GBX 654. The company has a quick ratio of 0.89, a current ratio of 5.79 and a debt-to-equity ratio of 1.70. The company’s 50 day moving average is GBX 358.53 and its two-hundred day moving average is GBX 428.25. The company has a market capitalization of £194.53 million, a price-to-earnings ratio of 1,180.44 and a beta of 1.14.
Insider Transactions at MJ Gleeson
In related news, insider Fiona Clare Goldsmith bought 5,000 shares of MJ Gleeson stock in a transaction dated Wednesday, June 11th. The stock was purchased at an average cost of GBX 397 per share, with a total value of £19,850. Also, insider Nicola Bruce purchased 2,721 shares of the firm’s stock in a transaction dated Wednesday, July 9th. The shares were bought at an average price of GBX 370 per share, for a total transaction of £10,067.70. Insiders purchased a total of 7,943 shares of company stock worth $3,071,264 over the last three months. 13.22% of the stock is owned by insiders.
MJ Gleeson Company Profile
MJ Gleeson plc comprises two divisions: Gleeson Homes and Gleeson Land.
Gleeson Homes is the leading low-cost, affordable housebuilder with the vision of “Building Homes. Changing Lives.” Focusing on areas where affordable housing is most needed in the Midlands and North of England, Gleeson Homes’ average selling price was £193,900, 34% lower than other housebuilders average selling price of £291,700 in the same geographic regions.
Featured Stories
- Five stocks we like better than MJ Gleeson
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Take the Money and Run: Strategy Stock Looks Tapped Out
- What is the MACD Indicator and How to Use it in Your Trading
- Novartis’ Moonshot Cancer Therapy Could Be Future Growth Driver
- Insider Trades May Not Tell You What You Think
- Why These Banking Stocks Could Soar on Rate Cuts
Receive News & Ratings for MJ Gleeson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MJ Gleeson and related companies with MarketBeat.com's FREE daily email newsletter.
